Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells
Citation
Ma. Dao et al., Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells, BLOOD, 92(12), 1998, pp. 4612-4621
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
SICI code
0006-4971(199812)92:12<4612:ATFMRC>2.0.ZU;2-4
Abstract
Recent reports have indicated that there is poor engraftment from hematopoi
etic stem cells (HSC) that have traversed cell cycle ex vivo, However, indu
cing cells to cycle in culture is critical to the fields of ex vivo stem ce
ll expansion and retroviral-mediated gene therapy. Through the use of a xen
ograft model, the current data shows that human hematopoietic stem and prog
enitor cells can traverse M phase ex vivo, integrate retroviral vectors, en
graft, and sustain longterm hematopoiesis only if they have had the opportu
nity to engage their integrin receptors to fibronectin during the culture p
eriod. If cultured in suspension under the same conditions, transduction is
undetectable and the long-term multilineage regenerative capacity of the p
rimitive cells is severely diminished. (C) 1998 by The American Society of
Hematology.